Cite
Neurocognitive Function and Quality of Life Outcomes in the ONTRAC Study for Skin Cancer Chemoprevention by Nicotinamide.
MLA
Martin, Andrew J., et al. “Neurocognitive Function and Quality of Life Outcomes in the ONTRAC Study for Skin Cancer Chemoprevention by Nicotinamide.” Geriatrics (Basel, Switzerland), vol. 4, no. 1, Mar. 2019. EBSCOhost, https://doi.org/10.3390/geriatrics4010031.
APA
Martin, A. J., Dhillon, H. M., Vardy, J. L., Dalziell, R. A., Choy, B., Fernández-Peñas, P., Dixon, A., Renton, C., St George, G., Chinniah, N., Halliday, G. M., Damian, D. L., & Chen, A. C. (2019). Neurocognitive Function and Quality of Life Outcomes in the ONTRAC Study for Skin Cancer Chemoprevention by Nicotinamide. Geriatrics (Basel, Switzerland), 4(1). https://doi.org/10.3390/geriatrics4010031
Chicago
Martin, Andrew J, Haryana M Dhillon, Janette L Vardy, Robyn A Dalziell, Bonita Choy, Pablo Fernández-Peñas, Ann Dixon, et al. 2019. “Neurocognitive Function and Quality of Life Outcomes in the ONTRAC Study for Skin Cancer Chemoprevention by Nicotinamide.” Geriatrics (Basel, Switzerland) 4 (1). doi:10.3390/geriatrics4010031.